| Recruitment status | Main results already published |
| Unique ID issued by UMIN | UMIN000019494 |
| Receipt No. | R000022544 |
| Scientific Title | Effect of a plant derived beverage on energy metabolism |
| Date of disclosure of the study information | 2015/10/26 |
| Last modified on | 2020/02/18 (Ver. 11) |
| Basic information | ||
| Public title | Effect of a plant derived beverage on energy metabolism | |
| Acronym | Effect of a plant derived beverage on energy metabolism | |
| Scientific Title | Effect of a plant derived beverage on energy metabolism | |
| Scientific Title:Acronym | Effect of a plant derived beverage on energy metabolism | |
| Region |
|
|
| Condition | |||
| Condition | Healthy adults | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | To investigate the effect of a plant derived beverage on energy metabolism |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Medical examination regarding energy expenditure including lipid and carbohydrate prior to intervention and at 4 weeks consumption |
| Key secondary outcomes | Analysis of blood and urine |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Cross-over |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Double blind -all involved are blinded |
| Control | Placebo |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Control beverage (product code: P0001) 4 weeks consumption > wash out 4 weeks > test beverage (product code: A0001) 4 weeks consumption | |
| Interventions/Control_2 | Test beverage (product code: A0001) 4 weeks consumption > wash out 4 weeks > control beverage (product code: P0001) 4 weeks consumption | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male | |||
| Key inclusion criteria | (1)Subjects who have given written informed consent prior to start of study.
(2)Male workers at Kao Corporation. (3)Age>=30 and <60 years (4)BMI>=23 and <30 |
|||
| Key exclusion criteria | (1)Subjects who take a medicine.
(2)Subjects who have a history of heart disease. (3)Subjects who have a history or signs of a cerebrovascular disease. (4)Subjects having a liver, kidney, or heart disease, cardiovascular disease, respiratory disorder, endocrine disorder, metabolic disorder, organ disorder, gout, rheumatism, autoimmune disease, allergy disease, mental disorder, cancer, infection disease, or other diseases. (5)Subjects who have donated over 200 mL of blood within the last one month prior to the current study or over 400 mL of blood within the last three months prior to the current study. (6)Subjects who have severe anemia (Hb <=7g/dL). (7)Subjects who have allergic reaction to food. (8)Subjects who have sensitivity to control or test beverage. (9)Subjects who are planned to participate in other clinical study during current study. (10)Subjects who are judged to be inappropriate for the study by the medical doctor or investigator for other reason. |
|||
| Target sample size | 20 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Kao Corporation | ||||||
| Division name | Health Care Food Research Laboratories | ||||||
| Zip code | 131-8501 | ||||||
| Address | 2-1-3, Bunka, Sumida-ku, Tokyo, 131-8501, Japan | ||||||
| TEL | 03-5630-7224 | ||||||
| osaki.noriko@kao.co.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Kao Corporation | ||||||
| Division name | Health Care Food Research Laboratories | ||||||
| Zip code | 131-8501 | ||||||
| Address | 2-1-3, Bunka, Sumida-ku, Tokyo, 131-8501, Japan | ||||||
| TEL | 03-5630-7266 | ||||||
| Homepage URL | |||||||
| katada.shun@kao.co.jp | |||||||
| Sponsor | |
| Institute | Kao Corporation |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Kao Corporation |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Human Research Ethics Committee, Kao Corporation |
| Address | 2-1-3, Bunka, Sumida-ku, Tokyo, 131-8501, Japan |
| Tel | 03-5630-9220 |
| morisaki.naoko@kao.com | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 花王株式会社ヘルスケア食品研究所(東京都) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | Unpublished due to the protocol including the intellectual property rights |
| Publication of results | Published |
| Result | |||||||
| URL related to results and publications | https://www.mdpi.com/2072-6643/10/4/525/htm | ||||||
| Number of participants that the trial has enrolled | 15 | ||||||
| Results | Significant difference in the primary outcome between the groups |
||||||
| Results date posted |
|
||||||
| Results Delayed | |||||||
| Results Delay Reason | |||||||
| Date of the first journal publication of results | |||||||
| Baseline Characteristics | healthy male subjects |
||||||
| Participant flow | Fifteen subjects completed the trial and were analyzed. |
||||||
| Adverse events | None associated with the test beverage consumption |
||||||
| Outcome measures | Medical examination regarding energy expenditure including lipid and carbohydrate prior to intervention and at 4 weeks consumption |
||||||
| Plan to share IPD | |||||||
| IPD sharing Plan description | |||||||
| Progress | |||||||
| Recruitment status | Main results already published | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000022544 |